鞘内注射地塞米松辅助治疗重症带状疱疹病毒性脑膜脑炎1例报道
作者:
作者单位:

兰州大学第二医院神内ICU,甘肃 兰州 730030

作者简介:

王国娟(1990―),女,硕士,主治医师,主要从事神经重症感染性疾病的研究。Email:1094051282@qq.com。

通信作者:

梁成(1973―),男,博士,主任医师,主要从事神经系统感染与免疫性疾病的研究。Email:hongyan200107@126.com。

基金项目:


Intrathecal dexamethasone as adjunctive therapy for severe varicella-zoster virus meningoencephalitis: a case report
Author:
Affiliation:

Neurology Intensive Care Unit, The Second Hospital, Lanzhou University, Lanzhou, Gansu 730030, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    该文报道1例78岁男性重症带状疱疹病毒性(VZV)脑膜脑炎患者,合并乙型肝炎病毒活动性复制。经静脉阿昔洛韦治疗,患者意识仍进行性加重,且存在全身激素禁忌,免疫评估提示,患者中枢神经系统存在严重炎症,即脑脊液中白细胞介素(IL)-6显著升高,同时伴有全身免疫抑制状态,表现为血清IL-6/IL-10比值显著增高至17.58,且CD4+ T细胞减少。遂在持续抗病毒及支持治疗的基础上,联合鞘内注射地塞米松(5 mg/次,连续3 d)辅助治疗。治疗后患者意识迅速转清,脑脊液中IL-6/IL-10比值降至0.78。治疗及随访期间,未出现与操作相关或全身性并发症。该病例提示,对于存在全身激素禁忌的重症患者,鞘内注射地塞米松或可作为一种能够精准作用于中枢神经系统、同时避免全身性免疫抑制风险的辅助治疗选择。动态监测脑脊液中IL-6/IL-10比值或有助于评估中枢神经系统炎症状态,但其价值需进一步研究验证。

    Abstract:

    This article reports a case of a 78-year-old male with severe varicella-zoster virus meningoencephalitis, complicated by active hepatitis B virus replication. Despite intravenous acyclovir treatment, his consciousness deteriorated progressively. Systemic corticosteroids were contraindicated. Immunological assessment revealed severe inflammation in the central nervous system, indicated by significantly elevated interleukin (IL)-6 levels in the cerebrospinal fluid (CSF), accompanied by a systemic immunosuppressive state characterized by a markedly elevated serum IL-6/IL-10 ratio of 17.58 and reduced CD4+ T-cell counts. On the basis of continued antiviral and supportive therapy, adjunctive intrathecal dexamethasone (5 mg once daily for 3 consecutive days) was administered. Following treatment, the patient’s consciousness rapidly improved, and the CSF IL-6/IL-10 ratio decreased to 0.78. No procedure-related or systemic complications occurred during treatment or follow-up. This case suggests that for patients with severe varicella-zoster virus meningoencephalitis and contraindications to systemic corticosteroids, intrathecal dexamethasone may serve as a targeted adjunctive therapy that precisely modulates central nervous system inflammation while mitigating the risks of systemic immunosuppression. Dynamic monitoring of the CSF IL-6/IL-10 ratio may help assess the inflammatory status of the central nervous system, although its clinical value requires further validation.

    图1 患者头颅计算机体层成像横断位不同断面图像Fig.1
    图2 患者头颅磁共振成像横断位图像不同序列Fig.2
    表 1 鞘内注射地塞米松前后脑脊液指标变化Table 1
    参考文献
    相似文献
    引证文献
引用本文

王国娟,纪红琴,梁成456.鞘内注射地塞米松辅助治疗重症带状疱疹病毒性脑膜脑炎1例报道[J].国际神经病学神经外科学杂志,2026,(1):64-68111WANG Guojuan, JI Hongqin, LIANG Cheng222. Intrathecal dexamethasone as adjunctive therapy for severe varicella-zoster virus meningoencephalitis: a case report[J]. Journal of International Neurology and Neurosurgery,2026,(1):64-68

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-09-11
  • 最后修改日期:2026-01-29
  • 录用日期:
  • 在线发布日期: 2026-03-31
关闭
关闭
关于作者收到不明邮件或短信的再次申明

关闭